These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21142830)

  • 1. Effect of degree of methoxylation and particle size on compression properties and compactibility of pectin powders.
    Salbu L; Bauer-Brandl A; Alderborn G; Tho I
    Pharm Dev Technol; 2012; 17(3):333-43. PubMed ID: 21142830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct compression behavior of low- and high-methoxylated pectins.
    Salbu L; Bauer-Brandl A; Tho I
    AAPS PharmSciTech; 2010 Mar; 11(1):18-26. PubMed ID: 20013080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
    Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
    Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the physical interpretation of the initial bending of a Shapiro-Konopicky-Heckel compression profile.
    Klevan I; Nordström J; Bauer-Brandl A; Alderborn G
    Eur J Pharm Biopharm; 2009 Feb; 71(2):395-401. PubMed ID: 18940252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of particle fragmentation and deformation on the interparticulate bond formation process during powder compaction.
    Eriksson M; Alderborn G
    Pharm Res; 1995 Jul; 12(7):1031-9. PubMed ID: 7494798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified equation for particle bonding area and strength with inclusion of powder fragmentation propensity.
    Lamešić D; Planinšek O; Ilić IG
    Eur J Pharm Sci; 2018 Aug; 121():218-227. PubMed ID: 29857044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compression behavior classification system of pharmaceutical powders for accelerating direct compression tablet formulation design.
    Dai S; Xu B; Zhang Z; Yu J; Wang F; Shi X; Qiao Y
    Int J Pharm; 2019 Dec; 572():118742. PubMed ID: 31648016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preparation method on compactability of paracetamol granules and agglomerates.
    Fichtner F; Rasmuson AC; Alander EM; Alderborn G
    Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for alpha-lactose monohydrates.
    Haware RV; Tho I; Bauer-Brandl A
    Eur J Pharm Biopharm; 2009 Nov; 73(3):424-31. PubMed ID: 19698784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The compressibility and compactibility of different types of lactose.
    Ilić I; Kása P; Dreu R; Pintye-Hódi K; Srcic S
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1271-80. PubMed ID: 19466896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protocol for the classification of powder compression characteristics.
    Nordström J; Klevan I; Alderborn G
    Eur J Pharm Biopharm; 2012 Jan; 80(1):209-16. PubMed ID: 21946474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
    Rojas J; Buckner I; Kumar V
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between compactibility values and excipient cluster size using an in silico approach.
    Martínez L; Betz G; Villalobos R; Melgoza L; Young PM
    Drug Dev Ind Pharm; 2013 Feb; 39(2):374-81. PubMed ID: 22568747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can single particle compression and nanoindentation contribute to the understanding of pharmaceutical powder compression?
    Wünsch I; Michel S; Finke JH; John E; Juhnke M; Kwade A
    Eur J Pharm Biopharm; 2021 Aug; 165():203-218. PubMed ID: 34010689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of compressibility and compactibility parameters of roller compacted Theophylline and its binary mixtures.
    Hadžović E; Betz G; Hadžidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2011 Sep; 416(1):97-103. PubMed ID: 21704142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and powder characteristics of various citrus pectins and their application for oral pharmaceutical tablets.
    Chomto P; Nunthanid J
    Carbohydr Polym; 2017 Oct; 174():25-31. PubMed ID: 28821065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tabletting speed on compactibility and compressibility of two direct compressible powders under high speed compression.
    Ishino R; Yoshino H; Hirakawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1987-92. PubMed ID: 2268901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the tensile strength of compacted multi-component mixtures of pharmaceutical powders.
    Wu CY; Best SM; Bentham AC; Hancock BC; Bonfield W
    Pharm Res; 2006 Aug; 23(8):1898-905. PubMed ID: 16850273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.